➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Medtronic
McKinsey
Colorcon
AstraZeneca

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

TRANMEP Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Tranmep patents expire, and when can generic versions of Tranmep launch?

Tranmep is a drug marketed by Solvay and is included in two NDAs.

The generic ingredient in TRANMEP is meprobamate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meprobamate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tranmep

A generic version of TRANMEP was approved as meprobamate by INVAGEN PHARMS on February 27th, 2008.

  Try it Free

Drug patent expirations by year for TRANMEP
Anatomical Therapeutic Chemical (ATC) Classes for TRANMEP

US Patents and Regulatory Information for TRANMEP

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay TRANMEP meprobamate TABLET;ORAL 084369-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Solvay TRANMEP meprobamate TABLET;ORAL 016249-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Medtronic
McKinsey
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.